Abstract
A biosensor using a composite polymer to prevent interferences was used in a flow injection analysis system for the detection of galactose in human plasma. The biosensor consisted of galactose oxidase immobilized on a platinized carbon electrode that had been modified with a composite polymer. The composite polymer showed improved selectivity to hydrogen peroxide compared with either of its individual polymeric components, Nafion and a copolymer of diaminobenzene and resorcinol. The composite polymer minimized the effect of possible interference from urate, ascorbate, and acetaminophen. This analytical system has a minimum detection limit of 50 μM, linearity to 6 mM, a storage stability of greater than 30 days, and a high sample throughput (approx. 120 samples/h).
Original language | English (US) |
---|---|
Pages (from-to) | 359-370 |
Number of pages | 12 |
Journal | Biosensors and Bioelectronics |
Volume | 10 |
Issue number | 3-4 |
DOIs | |
State | Published - 1995 |
All Science Journal Classification (ASJC) codes
- Biotechnology
- Biophysics
- Biomedical Engineering
- Electrochemistry
Keywords
- 1
- 3-diaminobenzene
- 3-phenylenediamine
- Nafion
- biosensor
- composite polymer
- electropolymerization
- galactose
- galactose oxidase
- interferences